Skip to content
Screener

Replimune Group REPL Q2 2026 earnings

Reported November 6, 2025 · Before market open

EPS-$0.90Miss by $0.03
Revenue estimate$714.3K
EPS estimate-$0.87

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.0M
EPS estimate-$0.75

Financials

Q2 2026

Income statement

See full
Operating income-$84.3M-43.1%
Net income-$83.1M-56.6%
EPS (diluted)-$0.90-32.4%

Balance sheet

See full
Cash & equivalents$104.0M-9.7%
Total debt$79.2M+0.4%
Total equity$263.3M-31.0%
Total assets$389.5M-21.8%

Cash flow

See full
Operating cash flow-$81.2M-110%
CapEx$1.3M-35.6%
Free cash flow-$82.6M-103%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$327.05M-56.9%
Enterprise value$302.22M-58.1%

Returns & leverage

See full
Return on equity-96.2%+1,002pp
Debt / equity0.3×+0.1×
Current ratio6.3×-3.8×

FAQ

When did Replimune Group report Q2 2026 earnings?
Replimune Group (REPL) reported Q2 2026 earnings on November 6, 2025 before market open.
What were Replimune Group's Q2 2026 revenue and EPS?
Replimune Group reported eps of $-0.90 for Q2 2026.
Did Replimune Group beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.87 by $0.03.
How did Replimune Group's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 32.4% from $-0.68.
Where can I find Replimune Group's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-25-107438) and the 10-Q periodic report (0001628280-25-049884) directly on SEC EDGAR. The filing index links above go to sec.gov.